Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease
一项评估Fc优化FLT3抗体FLYSYN在伴有可测量残留病灶的急性髓系白血病患者中疗效的I期研究
期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-023-01490-w
Heitmann, Jonas S; Schlenk, Richard F; Dörfel, Daniela; Kayser, Sabine; Döhner, Konstanze; Heuser, Michael; Thol, Felicitas; Kapp-Schwoerer, Silke; Labrenz, Jannik; Edelmann, Dominic; Märklin, Melanie; Vogel, Wichard; Bethge, Wolfgang; Walz, Juliane S; Große-Hovest, Ludger; Steiner, Martin; Jung, Gundram; Salih, Helmut R